152 related articles for article (PubMed ID: 2175672)
1. Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.
Kirkwood JM; Robinson JE
Cancer Immunol Immunother; 1990; 32(4):228-34. PubMed ID: 2175672
[TBL] [Abstract][Full Text] [Related]
2. Analysis of two human monoclonal antibodies against melanoma.
Yeilding NM; Gerstner C; Kirkwood JM
Int J Cancer; 1992 Dec; 52(6):967-73. PubMed ID: 1459738
[TBL] [Abstract][Full Text] [Related]
3. Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation.
Steinitz M; Koskimies S; Klein G; Mäkelä O
J Clin Lab Immunol; 1979 Apr; 2(1):1-7. PubMed ID: 95800
[TBL] [Abstract][Full Text] [Related]
4. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
5. In vitro production of human antibodies specifically reactive with human gastric cancer cells of established lines and autologous tissues.
Takayama T; Sakabe T; Fujii M; Yamada E; Uno M; Ono Y
J Surg Oncol; 1987 Nov; 36(3):215-24. PubMed ID: 2824934
[TBL] [Abstract][Full Text] [Related]
6. In vitro growth of B lymphocytes infiltrating human melanoma tissue by transformation with EBV: evidence for secretion of anti-melanoma antibodies by some transformed cells.
Watson DB; Burns GF; Mackay IR
J Immunol; 1983 May; 130(5):2442-7. PubMed ID: 6300247
[TBL] [Abstract][Full Text] [Related]
7. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
8. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease.
Li H; Akamizu T; Okuda J; Sugawa H; Matsuda F; Tsubata T; Mori T
Biochem Biophys Res Commun; 1995 Feb; 207(3):985-93. PubMed ID: 7864905
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal IgM, IgG, and IgA human rheumatoid factors produced by synovial tissue-derived, EBV-transformed B cell lines.
Kaplan S; Hyman K; Brooks R; Wakai M; Hashimoto S; Furie R; Chiorazzi N
Clin Immunol Immunopathol; 1993 Jan; 66(1):18-25. PubMed ID: 8382569
[TBL] [Abstract][Full Text] [Related]
10. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma.
Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P
Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441
[TBL] [Abstract][Full Text] [Related]
11. Epstein Barr virus transformation of peripheral blood B cells secreting antibodies reactive with cell surface antigens.
Posner MR; Elboim HS; Tumber MB
Autoimmunity; 1990; 8(2):149-58. PubMed ID: 1966543
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a new Epstein-Barr virus-immortalized cell line from chronic lymphocytic leukemia with trisomy of chromosome 12 that produces monoclonal IgM against a sheep RBC antigen.
Crescenzi M; Napolitano M; Carbonari M; Antonelli A; Petrinelli P; Gaetano C; Fiorilli M
Blood; 1988 Jan; 71(1):9-12. PubMed ID: 2825846
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and responses of EBV immortalized B cells from periodontal disease patients.
Celenligil H; Ebersole JL
Oral Dis; 1997 Dec; 3(4):262-71. PubMed ID: 9643223
[TBL] [Abstract][Full Text] [Related]
15. Production of human monoclonal antibodies by the epstein-barr virus method.
Steinitz M
Methods Mol Biol; 2014; 1060():111-22. PubMed ID: 24037838
[TBL] [Abstract][Full Text] [Related]
16. Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes.
Smith LH; Yin A; Bieber M; Teng NN
J Immunol Methods; 1987 Dec; 105(2):263-73. PubMed ID: 2826600
[TBL] [Abstract][Full Text] [Related]
17. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies.
Livingston P; Zhang S; Adluri S; Yao TJ; Graeber L; Ragupathi G; Helling F; Fleisher M
Cancer Immunol Immunother; 1997 Jan; 43(6):324-30. PubMed ID: 9067403
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies reactive with cell surface antigens on human leukemia cell lines: many antibodies are (auto)antibodies.
Posner MR; Elboim HS; Tumber MB; Cannon TJ
Hybridoma; 1990 Apr; 9(2):97-110. PubMed ID: 2161404
[TBL] [Abstract][Full Text] [Related]
20. Production of antibody to human osteosarcoma associated antigens by continuous human lymphoblastoid cell lines.
Tsang KY; Pan JF; Fudenberg HH
Immunol Lett; 1984; 7(5):267-72. PubMed ID: 6202625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
